AstraZeneca partners with insitro on $1.86 billion AI drug discovery deal
AstraZeneca signed a collaboration with machine learning biotech insitro worth up to $1.86 billion to discover new medicines for liver and heart diseases using AI-driven drug discovery platforms.
